GDC-0214 is an investigational, inhaled small molecule that selectively inhibits JAK1. It has been shown to reduce fractional exhaled nitric oxide (FeNO), a biomarker of airway inflammation, in preclinical research relevant to asthma and other respiratory diseases.
Molecular Weight:
612.03
Purity:
99.75% (May vary between batches)
CAS Number:
[1831144-46-7]
Formula:
C28H28ClF2N9O3
Target:
JAK,STAT
Application Notes:
Solubility: DMSO:9 mg/mL (14.71 mM)
* VAT and and shipping costs not included. Errors and price changes excepted